These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28681248)

  • 1. Sinus floor elevation using implants coated with recombinant human bone morphogenetic protein-2: micro-computed tomographic and histomorphometric analyses.
    Thoma DS; Yoon SR; Cha JK; Lim HC; Lee JS; Choi SH; Jung UW
    Clin Oral Investig; 2018 Mar; 22(2):829-837. PubMed ID: 28681248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation.
    Boyne PJ; Lilly LC; Marx RE; Moy PK; Nevins M; Spagnoli DB; Triplett RG
    J Oral Maxillofac Surg; 2005 Dec; 63(12):1693-707. PubMed ID: 16297689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
    Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
    J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinus augmentation using a mini-pig model: Effect of ceramic and allogeneic bone biomaterials.
    Susin C; Fiorini T; Lee J; de Freitas RM; Chiu HC; Prasad HS; Buxton AN; Wikesjö UME
    J Clin Periodontol; 2017 Oct; 44(10):1059-1066. PubMed ID: 28644556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinus augmentation using rhBMP-2/ACS in a mini-pig model: relative efficacy of autogenous fresh particulate iliac bone grafts.
    Lee J; Susin C; Rodriguez NA; de Stefano J; Prasad HS; Buxton AN; Wikesjö UM
    Clin Oral Implants Res; 2013 May; 24(5):497-504. PubMed ID: 22276816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs.
    Decker JF; Lee J; Cortella CA; Polimeni G; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Periodontol; 2010 Dec; 81(12):1839-49. PubMed ID: 20629551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
    Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
    Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone response to the multilayer BMP-2 gene coated porous titanium implant surface.
    Jiang QH; Liu L; Peel S; Yang GL; Zhao SF; He FM
    Clin Oral Implants Res; 2013 Aug; 24(8):853-61. PubMed ID: 22168601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration.
    Ramazanoglu M; Lutz R; Ergun C; von Wilmowsky C; Nkenke E; Schlegel KA
    Clin Oral Implants Res; 2011 Dec; 22(12):1433-9. PubMed ID: 21418332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and platelet-rich fibrin-mixed tricalcium phosphate in rabbits.
    Kim BJ; Kwon TK; Baek HS; Hwang DS; Kim CH; Chung IK; Jeong JS; Shin SH
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):583-92. PubMed ID: 22676983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Implant Placement after Bone Augmentation of Severely Resorbed Maxillary Sinuses with 'Tent-Pole' Grafting Technique in Combination with rhBMP-2.
    Zhang Q; Zhang LL; Yang Y; Lin YZ; Miron RJ; Zhang YF
    Chin J Dent Res; 2017; 20(1):9-17. PubMed ID: 28232962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
    Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of a human autopsy case in maxillary sinuses augmented using a synthetic bone substitute: Micro-computed tomographic and histologic observations.
    Lee JS; Cha JK; Thoma DS; Jung UW
    Clin Oral Implants Res; 2018 Mar; 29(3):339-345. PubMed ID: 29349884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implant-guided vertical bone growth in the mini-pig.
    Freilich M; Wen B; Shafer D; Schleier P; Dard M; Pendrys D; Ortiz D; Kuhn L
    Clin Oral Implants Res; 2012 Jun; 23(6):751-757. PubMed ID: 21810121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of SLA® or SLActive® implants placed in the maxillary sinus with or without synthetic bone graft materials--an animal study in sheep.
    Philipp A; Duncan W; Roos M; Hämmerle CH; Attin T; Schmidlin PR
    Clin Oral Implants Res; 2014 Oct; 25(10):1142-8. PubMed ID: 24112524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combination of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointegration by confocal laser scanning microscopy.
    Lan J; Wang Z; Wang Y; Wang J; Cheng X
    J Periodontol; 2006 Mar; 77(3):357-63. PubMed ID: 16512749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model.
    Hall J; Sorensen RG; Wozney JM; Wikesjö UM
    J Clin Periodontol; 2007 May; 34(5):444-51. PubMed ID: 17448048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human bone morphogenetic protein 2 outcomes for maxillary sinus floor augmentation: a systematic review and meta-analysis.
    Lin GH; Lim G; Chan HL; Giannobile WV; Wang HL
    Clin Oral Implants Res; 2016 Nov; 27(11):1349-1359. PubMed ID: 26620161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.